<DOC>
	<DOCNO>NCT01552772</DOCNO>
	<brief_summary>This study test safety aripiprazole injection subject schizophrenia currently take oral antipsychotic medication aripiprazole . Subjects study receive one injection aripiprazole need stop take antipsychotic medication two week injection . The study last one month . Subjects require come clinic evaluation drug urine collection five time course study .</brief_summary>
	<brief_title>Safety Tolerability Trial Aripiprazole IM Depot Treatment Adult Subjects With Schizophrenia Stabilized Oral Antipsychotics Other Than Aripiprazole</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Male female individual 18 64 year age , inclusive , diagnosis schizophrenia define DSMIVTR criterion . 2 . Good physical health determine clinically significant deviation normal medical history , clinical laboratory determination , ECGs , physical examination . 3 . Ability provide write informed consent consent obtain legally acceptable representative ( require IRB ) prior initiation protocolrequired procedure . 4 . Body mass index 18 35 kg/m2 , inclusive . 5 . Prior history tolerate aripiprazole . 6 . Subjects must treat one follow atypical oral antipsychotic medication : risperidone , olanzapine , quetiapine , ziprasidone , paliperidone clinically stable , per investigator 's judgment , 14 day prior administration aripiprazole IM depot 1 . Sexually active male commit utilizing 2 approve birth control method remain abstinent trial 180 day follow last dose trial medication , orchidectomy sexually active female childbearing potential commit utilize 2 approved birth control method remain abstinent trial 150 day follow last dose trial medication . Abstinence permit confirm documented every trial visit . If employing birth control , 2 follow precaution must use : vasectomy , tubal ligation , vaginal diaphragm , intrauterine device , birth control pill , birth control depot injection , implant , condom sponge spermicide . Note : Women childbearing potential ( WOCBP ) define woman unless oophorectomy hysterectomy postmenopausal 12 consecutive month . 2 . Subjects meet DSMIVTR criterion substance abuse dependence within past 180 day ; include alcohol benzodiazepine , exclude caffeine nicotine . Subjects positive drug screen cocaine drug abuse ( exclude stimulant prescribe medication marijuana ) .a 3 . Subjects likely require prohibit concomitant therapy trial , use CYP2D6 CYP3A4 inhibitor , CYP3A4 inducer within 14 day prior dose duration trial . 4 . Females pregnant lactating . 5 . Subjects participate clinical trial involve psychotropic medication within 1 month prior enrollment ; subject participate previous IM depot trial within last 6 month ; previously enrol received trial medication aripiprazole IM depot clinical trial . 6 . Any major surgery within 30 day prior enrollment . 7 . Evidence organ dysfunction clinically significant deviation normal physical , electrocardiographic , clinical laboratory examination . 8 . Subjects significant risk commit suicide base history routine psychiatric status examination 9 . Subjects currently acute relapse schizophrenia . 10 . Subjects current DSMIVTR diagnosis schizophrenia , include schizoaffective disorder , major depressive disorder , bipolar disorder , delirium , dementia , amnestic cognitive disorder . Also , subject borderline , paranoid , histrionic , schizotypal , schizoid , antisocial personality disorder . 11 . Subjects consider treatmentresistant antipsychotic medication . ( Subjects need show previous response antipsychotic medication clozapine . ) 12 . Subjects history neuroleptic malignant syndrome clinically significant tardive dyskinesia . 13 . Subjects know allergic , intolerant , unresponsive prior treatment aripiprazole quinolinones .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>